Research | Page 22 of 22

Diabetes UK to Fund New Diabetes Research

Diabetes UK announced that it would be dedicating almost £750,000 ($1,200,000) to four new research projects looking to understand the causes of diabetes, help with its day-to-day management and protect against its complications. "We are delighted to be supporting this new research and hope that it will bring benefit and improvements for people living...

First Human Embryonic Stem Cell Lines Approved for Use Under New NIH Guidelines

The National Institute of Health (NIH) announced the approval of the first 13 human embryonic stem cell (hESC) lines for use in NIH-funded research under the NIH Guidelines for Human Stem Cell Research adopted in July 2009. Children's Hospital Boston developed 11 of the approved lines and Rockefeller University in New York City developed two of the approved lines....

Old Drug May Hold New Hope

A drug commonly used to treat non-Hodgkin's lymphoma and rheumatoid arthritis now also shows some promise in helping patients newly diagnosed with type 1 diabetes. The drug, rituximab (Rituxan) helped patients continue to produce some of their own insulin...

Success Rate of Islet Cells Transplants May Improve With New Treatment

TikoMed AB, a Swedish biotechnology company focused on development and commercialization of innovative treatments for immune diseases and cell therapies, announced that IBsolvMIR® has been granted orphan drug designation for the prevention of graft rejection of pancreatic islet transplantation by the U.S. Food and Drug Administration (FDA)...

Interview With Dr. George Eisenbarth

We can prevent diabetes in animal models and we are trying to figure out how to prevent it in man...

Interview with Kevan Herold: Doctor, Researcher, and Diabetic

I, like everyone else with diabetes, can find it tiring to never get a break from it...

Spherix Inc. Announces Positive Results for Type 2 Therapy

Spherix Inc., an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, and biotechnology companies, announced positive interim Phase 3 clinical results for the use of D-tagatose for treatment of type 2 diabetes patients...

Insulin Production Mechanism Discovered Which May Lead To Better Treatment of Diabetes

Researchers at the Hebrew University in Jerusalem, in collaboration with Japanese and American researchers, have discovered a mechanism of insulin production within the pancreas. The team, led by Prof. Yuval Dor, explored the role of LKB1, a gene involved in many cellular functions, whose role in the pancreas had not been examined before.

Diabetes Genetic Marker Discovered

Compugen Ltd. announced today the discovery and experimental confirmation of a genetic marker for type 2 diabetes. A predisposition marker is of particular value in type 2 diabetes since lifestyle plays an important role in the disease. Following diagnosis, those at high-risk might benefit from more aggressive management either through changes in lifestyle or drug treatment.